MARK G FOLETTA Insider Trading $TOCA Forte Biosciences, Inc.
Get free email notifications about insider trading for MARK G FOLETTA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK G FOLETTA. MARK G FOLETTA is Senior VP, Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP & Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Director in AMN HEALTHCARE SERVICES INC ($AHS) and Director in DEXCOM INC ($DXCM) and Director in ENANTA PHARMACEUTICALS INC ($ENTA) and Interim CFO in BIOCEPT INC ($BIOC) and EVP & Chief Financial Officer in Tocagen Inc ($TOCA) and Director in Regulus Therapeutics Inc. ($RGLS).
MARK G FOLETTA in Forte Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK G FOLETTA: EVP & Chief Financial Officer
Holdings: 15,042 shares
Latest Transaction: Oct 04 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK G FOLETTA in Forte Biosciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AHS, AMLN, BIOC, DXCM, ENTA, TOCA, RGLS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 04 2019 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Option Exercise | A | 0.64 | 30,000 | 19,173 | 30,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Option Exercise | A | 0.64 | 30,000 | 19,173 | 30,000 | |
| May 29 2019 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Buy | P | 4.30 | 5,000 | 21,475 | 15,042 | 10 K to 15 K (+49.79 %) |
| Mar 02 2018 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Option Exercise | A | 11.19 | 85,000 | 951,150 | 85,000 | |
| Dec 14 2017 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Buy | J | 8.50 | 2,500 | 21,250 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| May 31 2017 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Option Exercise | A | 16.32 | 85,000 | 1,387,200 | 85,000 | |
| Apr 21 2017 | TOCA | Tocagen Inc | FOLETTA MARK G | EVP & Chief Financi ... | Buy | P | 10.00 | 5,000 | 50,000 | 5,000 | 0 to 5 K |
Page: 1